(AKZA) Akzo Nobel - Overview
Sector: Basic Materials | Industry: Specialty Chemicals | Exchange: AS (Netherlands) | Market Cap: 8.692m EUR | Total Return: -14.6% in 12m
Decorative Paints, Industrial Coatings, Enamels, Varnishes, Surface Preparation
Total Rating 46
Safety 72
Buy Signal -0.54
Specialty Chemicals
Industry Rotation: -7.9
Industry Rotation: -7.9
Market Cap:
10.2B
Avg Turnover: 24.6M
Avg Turnover: 24.6M
Risk 3d forecast
Volatility28.9%
VaR 5th Pctl4.97%
VaR vs Median4.14%
Reward TTM
Sharpe Ratio-0.67
Rel. Str. IBD14.5
Rel. Str. Peer Group10.6
Character TTM
Beta0.461
Beta Downside0.535
Hurst Exponent0.494
Drawdowns 3y
Max DD35.35%
CAGR/Max DD-0.26
CAGR/Mean DD-0.48
EPS (Earnings per Share)
EPS CAGR: 1.55%
EPS Trend: -18.5%
EPS Trend: -18.5%
Last SUE: 0.10
Qual. Beats: 0
Qual. Beats: 0
Revenue
Rev. CAGR: -4.65%
Rev. Trend: -75.8%
Rev. Trend: -75.8%
Last SUE: 0.72
Qual. Beats: 0
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Description: AKZA Akzo Nobel
Akzo Nobel N.V. is a Netherlands-based global producer of paints and coatings, operating primarily through its Decorative Paints and Performance Coatings segments. The company manages an extensive portfolio of international brands, including Dulux, Sikkens, and International, providing specialized solutions for surface preparation, corrosion control, and fire protection across various industrial and consumer applications.
As a major player in the Specialty Chemicals sector, the business model relies on high R&D investment to meet evolving environmental regulations and functional requirements for the aerospace, automotive, and marine industries. The coatings market is characterized by consolidated global competition where raw material price fluctuations and construction cycles significantly influence profit margins. You may find further insights into these valuation drivers by examining the data on ValueRay.
The company serves diverse end-markets, including energy, infrastructure, and shipbuilding, utilizing a distribution network that spans mixing machines, professional training, and retail sales. Founded in 1646, Akzo Nobel maintains a dominant position in the protective coatings space, focusing on engineered performance properties for large-scale industrial assets and consumer goods.
- Raw material price fluctuations impact gross margins for decorative and performance segments
- European construction sector downturn pressures decorative paint demand and sales volumes
- Marine and aerospace coatings demand drives performance segment revenue growth
- Cost transformation initiatives and efficiency programs influence long-term operating profit margins
- Global industrial production trends dictate demand for high-performance protective coatings
Piotroski VR‑10 (Strict)
7.5
| Net Income: 621.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.60 > 1.0 |
| NWC/Revenue: 31.62% < 20% (prev 16.22%; Δ 15.40% < -1%) |
| CFO/TA 0.06 > 3% & CFO 956.0m > Net Income 621.0m |
| Net Debt (3.35b) to EBITDA (1.59b): 2.11 < 3 |
| Current Ratio: 1.72 > 1.5 & < 3 |
| Outstanding Shares: last quarter (171.2m) vs 12m ago -0.80% < -2% |
| Gross Margin: 40.07% > 18% (prev 0.40%; Δ 3.97k% > 0.5%) |
| Asset Turnover: 65.47% > 50% (prev 71.95%; Δ -6.47% > 0%) |
| Interest Coverage Ratio: 6.19 > 6 (EBITDA TTM 1.59b / Interest Expense TTM 196.0m) |
Altman Z''
3.51
| A: 0.20 (Total Current Assets 7.53b - Total Current Liabilities 4.39b) / Total Assets 15.49b |
| B: 0.35 (Retained Earnings 5.48b / Total Assets 15.49b) |
| C: 0.08 (EBIT TTM 1.21b / Avg Total Assets 15.17b) |
| D: 0.47 (Book Value of Equity 4.88b / Total Liabilities 10.43b) |
| Altman-Z'' Score: 3.51 = A |
Beneish M
-3.13
| DSRI: 1.02 (Receivables 2.83b/2.98b, Revenue 9.93b/10.68b) |
| GMI: 1.00 (GM 40.07% / 40.23%) |
| AQI: 0.91 (AQ_t 0.36 / AQ_t-1 0.40) |
| SGI: 0.93 (Revenue 9.93b / 10.68b) |
| TATA: -0.02 (NI 621.0m - CFO 956.0m) / TA 15.49b) |
| Beneish M-Score: -3.13 (Cap -4..+1) = AA |
What is the price of AKZA shares?
As of May 16, 2026, the stock is trading at EUR 49.00 with a total of 399,186 shares traded.
Over the past week, the price has changed by -3.43%, over one month by -0.81%, over three months by -17.24% and over the past year by -14.61%.
Over the past week, the price has changed by -3.43%, over one month by -0.81%, over three months by -17.24% and over the past year by -14.61%.
Is AKZA a buy, sell or hold?
Akzo Nobel has no consensus analysts rating.
What are the forecasts/targets for the AKZA price?
| Analysts Target Price | - | - |
Akzo Nobel (AKZA) - Fundamental Data Overview
as of 11 May 2026
Market Cap USD = 10.18b (8.69b EUR * 1.1715 EUR.USD)P/E Trailing = 14.0166
P/E Forward = 12.7226
P/S = 0.8752
P/B = 1.7807
P/EG = 0.9935
Revenue TTM = 9.93b EUR
EBIT TTM = 1.21b EUR
EBITDA TTM = 1.59b EUR
Long Term Debt = 3.48b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.35b EUR (from shortTermDebt, last quarter)
Debt = 6.11b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.35b EUR (from netDebt column, last quarter)
Enterprise Value = 11.77b EUR (8.69b + Debt 6.11b - CCE 3.03b)
Interest Coverage Ratio = 6.19 (Ebit TTM 1.21b / Interest Expense TTM 196.0m)
EV/FCF = 17.83x (Enterprise Value 11.77b / FCF TTM 660.0m)
FCF Yield = 5.61% (FCF TTM 660.0m / Enterprise Value 11.77b)
FCF Margin = 6.65% (FCF TTM 660.0m / Revenue TTM 9.93b)
Net Margin = 6.25% (Net Income TTM 621.0m / Revenue TTM 9.93b)
Gross Margin = 40.07% ((Revenue TTM 9.93b - Cost of Revenue TTM 5.95b) / Revenue TTM)
Gross Margin QoQ = 40.99% (prev 39.46%)
Tobins Q-Ratio = 0.76 (Enterprise Value 11.77b / Total Assets 15.49b)
Interest Expense / Debt = 0.65% (Interest Expense 40.0m / Debt 6.11b)
Taxrate = 31.76% (47.0m / 148.0m)
NOPAT = 827.8m (EBIT 1.21b * (1 - 31.76%))
Current Ratio = 1.72 (Total Current Assets 7.53b / Total Current Liabilities 4.39b)
Debt / Equity = 1.25 (Debt 6.11b / totalStockholderEquity, last quarter 4.88b)
Debt / EBITDA = 2.11 (Net Debt 3.35b / EBITDA 1.59b)
Debt / FCF = 5.07 (Net Debt 3.35b / FCF TTM 660.0m)
Total Stockholder Equity = 4.41b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.09% (Net Income 621.0m / Total Assets 15.49b)
RoE = 14.08% (Net Income TTM 621.0m / Total Stockholder Equity 4.41b)
RoCE = 15.38% (EBIT 1.21b / Capital Employed (Equity 4.41b + L.T.Debt 3.48b))
RoIC = 18.11% (NOPAT 827.8m / Invested Capital 4.57b)
WACC = 4.65% (E(8.69b)/V(14.80b) * Re(7.61%) + D(6.11b)/V(14.80b) * Rd(0.65%) * (1-Tc(0.32)))
Discount Rate = 7.61% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares (quarterly) Correlation: 38.65 | Cagr: 0.16%
[DCF] Terminal Value 86.21% ; FCFF base≈554.0m ; Y1≈547.1m ; Y5≈566.2m
[DCF] Fair Price = 78.82 (EV 16.85b - Net Debt 3.35b = Equity 13.50b / Shares 171.3m; r=6.0% [WACC]; 5y FCF grow -2.06% → 3.0% )
EPS Correlation: -18.50 | EPS CAGR: 1.55% | SUE: 0.10 | # QB: 0
Revenue Correlation: -75.77 | Revenue CAGR: -4.65% | SUE: 0.72 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.16 | Chg30d=+0.93% | Revisions=-33% | Analysts=4
EPS next Quarter (2026-09-30): EPS=0.97 | Chg30d=-8.64% | Revisions=-33% | Analysts=3
EPS current Year (2026-12-31): EPS=3.87 | Chg30d=-2.70% | Revisions=-53% | GrowthEPS=+6.7% | GrowthRev=-0.9%
EPS next Year (2027-12-31): EPS=4.25 | Chg30d=-3.21% | Revisions=-47% | GrowthEPS=+9.8% | GrowthRev=+2.2%
[Analyst] Revisions Ratio: -53%